JP2023522615A5 - - Google Patents

Info

Publication number
JP2023522615A5
JP2023522615A5 JP2022562424A JP2022562424A JP2023522615A5 JP 2023522615 A5 JP2023522615 A5 JP 2023522615A5 JP 2022562424 A JP2022562424 A JP 2022562424A JP 2022562424 A JP2022562424 A JP 2022562424A JP 2023522615 A5 JP2023522615 A5 JP 2023522615A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
infection
composition according
pharmaceutically acceptable
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562424A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522615A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/059504 external-priority patent/WO2021209419A1/en
Publication of JP2023522615A publication Critical patent/JP2023522615A/ja
Publication of JP2023522615A5 publication Critical patent/JP2023522615A5/ja
Priority to JP2026038584A priority Critical patent/JP2026120528A/ja
Pending legal-status Critical Current

Links

JP2022562424A 2020-04-14 2021-04-13 E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 Pending JP2023522615A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026038584A JP2026120528A (ja) 2020-04-14 2026-03-11 E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20169480 2020-04-14
EP20169480.9 2020-04-14
PCT/EP2021/059504 WO2021209419A1 (en) 2020-04-14 2021-04-13 Bi- and monocyclic nucleoside analogs for treatment of hepatitis e

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026038584A Division JP2026120528A (ja) 2020-04-14 2026-03-11 E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体

Publications (2)

Publication Number Publication Date
JP2023522615A JP2023522615A (ja) 2023-05-31
JP2023522615A5 true JP2023522615A5 (cg-RX-API-DMAC7.html) 2024-04-18

Family

ID=70289599

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022562424A Pending JP2023522615A (ja) 2020-04-14 2021-04-13 E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体
JP2026038584A Pending JP2026120528A (ja) 2020-04-14 2026-03-11 E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026038584A Pending JP2026120528A (ja) 2020-04-14 2026-03-11 E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体

Country Status (15)

Country Link
EP (1) EP4135715B1 (cg-RX-API-DMAC7.html)
JP (2) JP2023522615A (cg-RX-API-DMAC7.html)
KR (1) KR20230002592A (cg-RX-API-DMAC7.html)
CN (1) CN115515603A (cg-RX-API-DMAC7.html)
AR (1) AR121836A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021255809B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022020825A2 (cg-RX-API-DMAC7.html)
CA (1) CA3174790A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022002804A1 (cg-RX-API-DMAC7.html)
ES (1) ES2982564T3 (cg-RX-API-DMAC7.html)
MX (1) MX2022012904A (cg-RX-API-DMAC7.html)
PE (1) PE20230386A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022552679A1 (cg-RX-API-DMAC7.html)
UY (1) UY39172A (cg-RX-API-DMAC7.html)
WO (1) WO2021209419A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024086592A2 (en) * 2022-10-17 2024-04-25 Emory Unversity 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto
WO2025014360A1 (en) * 2023-07-07 2025-01-16 Erasmus University Medical Center Rotterdam Guanosine nucleotide analogs for use in preventing and/or treating hepatitis e virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2952714T3 (es) * 2013-06-26 2023-11-03 Janssen Pharmaceuticals Inc Nucleósidos sustituidos, nucleótidos y análogos de los mismos
US9603864B2 (en) * 2014-06-24 2017-03-28 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
SG11201610597QA (en) * 2014-06-24 2017-01-27 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
WO2017210438A1 (en) * 2016-06-03 2017-12-07 Gilead Pharmasset Llc Methods of treating hepatitis e viral infection

Similar Documents

Publication Publication Date Title
JP2013518107A5 (cg-RX-API-DMAC7.html)
JP2014504643A5 (cg-RX-API-DMAC7.html)
JP2021521118A5 (cg-RX-API-DMAC7.html)
JP2021513534A5 (cg-RX-API-DMAC7.html)
JP2013537905A5 (cg-RX-API-DMAC7.html)
JP2006526590A5 (cg-RX-API-DMAC7.html)
JP2012504126A5 (cg-RX-API-DMAC7.html)
JP2019515908A5 (cg-RX-API-DMAC7.html)
JP2015512860A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2020529994A5 (cg-RX-API-DMAC7.html)
RU2012117829A (ru) Фосфорамидатные производные нуклеозидов
JP2008518949A5 (cg-RX-API-DMAC7.html)
JP2013521279A5 (cg-RX-API-DMAC7.html)
JP2012528161A5 (cg-RX-API-DMAC7.html)
JP2009504763A5 (cg-RX-API-DMAC7.html)
JP2018135343A5 (cg-RX-API-DMAC7.html)
JP2016503800A5 (cg-RX-API-DMAC7.html)
JP2012513479A5 (cg-RX-API-DMAC7.html)
JP2020532547A5 (cg-RX-API-DMAC7.html)
JP2022514385A5 (cg-RX-API-DMAC7.html)
JP2014515377A5 (cg-RX-API-DMAC7.html)
JP2012522841A5 (cg-RX-API-DMAC7.html)
JP2005526833A5 (cg-RX-API-DMAC7.html)
JP2011526924A5 (cg-RX-API-DMAC7.html)